PURPOSE: To report the use of photodynamic therapy with @entity4936 as a treatment for @entity1 with focal retinal pigment epithelial leaks secondary to central @entity989 (CSC). DESIGN: Noncomparative, nonrandomized, retrospective interventional case series. @entity1 : Nine eyes of 9 symptomatic @entity1 with acute focal retinal pigment epithelial leaks secondary to CSC, confirmed with @entity941 angiography, evaluated at 1 of 3 referral retina practices. METHODS: @entity1 were treated with photodynamic therapy using @entity4936 . Best-corrected visual acuity (VA) was recorded at presentation and follow-up visits. MAIN OUTCOME MEASURES: Resolution of @entity1713 , status of @entity941 leakage, and VA. RESULTS: @entity1713 and @entity941 leakage resolved in all @entity1 within 1 month. Visual acuity improved from 1 to 6 lines in 7 eyes and remained unchanged in 2. At 6 months, there was a statistically significant improvement in mean VA (P = 0.012, Wilcoxon signed ranks test), and mean VA improved from 20/80 to 20/40. No @entity1 lost vision or suffered any treatment-related complications. CONCLUSION: The treatment of acute CSC with photodynamic therapy may result in prompt resolution of @entity1713 and @entity941 leakage, which can be associated with rapidly improved vision. Although this case series is limited in follow-up and number of @entity1 , the encouraging results and lack of visually significant complications suggest that further investigation is warranted.

Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central XXXX .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient', 'PARTICIPANTS'] @entity4936 :: ('MESH:C098350', 'Chemical') :: ['verteporfin'] @entity1713 :: ('MESH:D012163', 'Disease') :: ['Neurosensory detachment', 'neurosensory detachment'] @entity941 :: ('MESH:D019793', 'Chemical') :: ['fluorescein'] @entity989 :: ('MESH:D012164', 'Disease') :: ['serous chorioretinopathy']
@entity989 :: (MESH:D012164,Disease) :: ['serous chorioretinopathy']
